In a pancreas cancer model, loss of liver kinase B1 (LKB1) with KRAS activation induced serine and 1C metabolism, altering the epigenetic landscape by upregulating SAM levels and DNA methylation44. The gene discussed is STK11; the disease is pancreatic neoplasm.